1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INSMED INC
Insmed Inc XNAS: INSM

Insmed Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment...

Read More
145.81 -0.05 (-0.03%)
Near 52W High of $149.08
79,608
XNAS Volume

XNAS 19 Sep, 2025 9:49 AM (EDT)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
5.6 / 100
Valuation Score
Expensive Valuation
3.8 / 100
Momentum Score
Technically Moderately Bullish
65.7 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
159
1Yr Price target upside is 9%
16 analysts

15

S

15

W

1

O

1

T

SWOT Analysis

Insmed Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..